99 related articles for article (PubMed ID: 1677031)
1. The slow cyclic GMP increase caused by serotonin in NG108-15 cells is not inhibited by antagonists of known serotonin receptors: possible existence of a new receptor subtype coupled with membrane-bound guanylate cyclase.
Tohda M; Sakuma I; Nomura Y
J Neurochem; 1991 Aug; 57(2):714-7. PubMed ID: 1677031
[TBL] [Abstract][Full Text] [Related]
2. Serotonin stimulates both cytosolic and membrane-bound guanylate cyclase in NG108-15 cells.
Tohda M; Nomura Y
J Neurochem; 1990 Nov; 55(5):1800-5. PubMed ID: 1976761
[TBL] [Abstract][Full Text] [Related]
3. Studies on the activation mechanisms of guanylyl cyclase by serotonin, probably through a novel subtype of serotonin receptor (5-HTGC).
Tohda M; Imaizumi R; Sekiya A; Itoh N; Nomura Y
Biol Pharm Bull; 1995 Aug; 18(8):1072-5. PubMed ID: 8535398
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of stimulation of cyclic-GMP level in a neuronal cell line mediated by serotonin (5-HT3) receptors. Involvement of nitric oxide, arachidonic-acid metabolism and cytosolic Ca2+.
Reiser G
Eur J Biochem; 1990 May; 189(3):547-52. PubMed ID: 2161757
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine-induced Ca2+ -independent cGMP formation is mediated by nitric oxide in a nitric oxide synthase-independent manner in NG108-15 cells.
Arima T; Mizuno T; Ohshima Y; Kitamura Y; Segawa T; Nomura Y
Neurosci Res; 1997 Mar; 27(3):229-33. PubMed ID: 9129181
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP generation mediated by 5-HT-2 receptors via nitric oxide-dependent pathway and its effect on the desensitization of 5-HT-2 receptors in C6 glioma cells.
Kagaya A; Motohashi N; Kugaya A; Yamaji T; Hayashi T; Okamoto Y; Shinno H; Takebayashi M; Uchitomi Y; Yamawaki S
J Neural Transm Gen Sect; 1995; 100(1):27-38. PubMed ID: 8748661
[TBL] [Abstract][Full Text] [Related]
7. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis.
Chaki S; Inagami T
Mol Pharmacol; 1993 Apr; 43(4):603-8. PubMed ID: 7682650
[TBL] [Abstract][Full Text] [Related]
8. Endothelin and a Ca2+ ionophore raise cyclic GMP levels in a neuronal cell line via formation of nitric oxide.
Reiser G
Br J Pharmacol; 1990 Nov; 101(3):722-6. PubMed ID: 1963807
[TBL] [Abstract][Full Text] [Related]
9. Cyclic GMP elevation by 5-hydroxytryptamine is due to nitric oxide derived from endogenous nitrosothiol in NG108-15 cells.
Arima T; Ohshima Y; Mizuno T; Kitamura Y; Segawa T; Nomura Y
Biochem Biophys Res Commun; 1996 Oct; 227(2):473-8. PubMed ID: 8878539
[TBL] [Abstract][Full Text] [Related]
10. Chronic amitriptyline exposure reduces 5-HT3 receptor-mediated cyclic GMP formation in NG 108-15 cells.
Shimizu M; Nishida A; Zensho H; Yamawaki S
Brain Res; 1996 Nov; 741(1-2):89-94. PubMed ID: 9001709
[TBL] [Abstract][Full Text] [Related]
11. Dissection of bradykinin-evoked responses by buffering intracellular Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells.
Kimura Y; Higashida H
Neurosci Res; 1992 Nov; 15(3):213-20. PubMed ID: 1336834
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
Martin W; White DG; Henderson AH
Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide enhances activity of potassium conductance in adrenal glomerulosa cells.
Ganz MB; Nee JJ; Isales CM; Barrett PQ
Am J Physiol; 1994 May; 266(5 Pt 1):C1357-65. PubMed ID: 7515565
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
15. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
Ishii K; Chang B; Kerwin JF; Wagenaar FL; Huang ZJ; Murad F
J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of intracellular signaling systems by sodium fluoride in rat glioma cells.
Kagaya A; Uchitomi Y; Kugaya A; Takebayashi M; Nagaoka I; Muraoka M; Yokota N; Yamawaki S
J Neurochem; 1996 Apr; 66(4):1483-8. PubMed ID: 8627302
[TBL] [Abstract][Full Text] [Related]
18. Elevation of intracellular calcium levels contributes to the inhibition of nitric oxide production by atrial natriuretic peptide.
Kiemer AK; Vollmar AM
Immunol Cell Biol; 2001 Feb; 79(1):11-7. PubMed ID: 11168617
[TBL] [Abstract][Full Text] [Related]
19. Serotonin raises the cyclic GMP level in a neuronal cell line via 5-HT3 receptors.
Reiser G; Hamprecht B
Eur J Pharmacol; 1989 May; 172(2):195-8. PubMed ID: 2548882
[TBL] [Abstract][Full Text] [Related]
20. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.
Zhu CB; Hewlett WA; Feoktistov I; Biaggioni I; Blakely RD
Mol Pharmacol; 2004 Jun; 65(6):1462-74. PubMed ID: 15155839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
